Australia markets closed

Willow Biosciences Inc. (CANSF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.06850.0000 (0.00%)
At close: 01:14PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 7.90M
Enterprise value 7.16M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.97
Price/book (mrq)3.47
Enterprise value/revenue 6.11
Enterprise value/EBITDA -0.65

Trading information

Stock price history

Beta (5Y monthly) 1.07
52-week change 3-22.47%
S&P500 52-week change 322.38%
52-week high 30.1080
52-week low 30.0490
50-day moving average 30.0723
200-day moving average 30.0711

Share statistics

Avg vol (3-month) 316.52k
Avg vol (10-day) 312.16k
Shares outstanding 5126.96M
Implied shares outstanding 6128.3M
Float 896.89M
% held by insiders 127.34%
% held by institutions 10.12%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 321 May 2019
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 321 May 2019

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-3,094.38%

Management effectiveness

Return on assets (ttm)-67.87%
Return on equity (ttm)-131.54%

Income statement

Revenue (ttm)1.17M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-82.50%
Gross profit (ttm)N/A
EBITDA -12.62M
Net income avi to common (ttm)-13.03M
Diluted EPS (ttm)-0.0700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.78M
Total cash per share (mrq)0.03
Total debt (mrq)2.16M
Total debt/equity (mrq)62.75%
Current ratio (mrq)2.30
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-10.92M
Levered free cash flow (ttm)-6.23M